Diabetes Care

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes

By Jonathan Rosen, Ian H. de Boer, Robert H. Eckel, Sanjoy Dutta

ReviewInterventions

The paper

Jonathan Rosen, Ian H. de Boer, Robert H. Eckel, Sanjoy Dutta

Breakthrough T1D

Diabetes Care, 3 Sep 2026

doi.org/10.2337/dc26-0999 PubMed 42690158

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes